SNPRC at Texas Biomed awarded $37 million NIH grant to continue operations into 2026
The Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed) has been awarded more than $37 million from the National Institutes of Health (NIH) to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.
Non-human primates play an essential role in pre-clinical research, including most recently helping to show that the Pfizer-BioNTech COVID-19 vaccine would be safe and effective for humans, accelerating the clinical trials. The support from NIH for our Center will ensure that we can continue this critical work in finding new treatments and vaccines against a variety of infectious diseases, while maintaining the absolute highest
THAILAND: The government has allocated B2.8 billion to support COVID-19 vaccine research and development and the building of infrastructure, to support vaccine production, in order to develop Thailand
The government has allocated more than 2.8 billion baht to support Covid-19 vaccine research and development and push for Thailand to be a regional hub for vaccine production.
Yerkes NPRC/Emory University and Institut Pasteur researchers have determined adding a combination immunotherapy to antiviral therapy (ART) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models. This finding is key for reducing reliance on ART and developing additional treatment options to control HIV/AIDS.
E-Mail
(Media note: Interviews with Texas Biomed researchers are available with advanced notice. Photos and video of rhesus macaques and the Biosafety Level 3 & 4 laboratories at Texas Biomed are available upon request.)
SAN ANTONIO (April 27, 2021) - When the world was coming to grips with an emerging global pandemic a year ago, scientists at Texas Biomedical Research Institute sprang into action. The rhesus macaques at the Southwest National Primate Research Center (SNPRC) at Texas Biomed were quickly validated as models for studying vaccines designed to protect humans against SARS-CoV-2, the virus that causes COVID-19. The Pfizer-BioNTech COVID-19 vaccine was tested in this model at the Institute and has now been given to millions of people around the world.